Insider Selling: Goulart Steven J, MetLife Inc. [MET] EVP & Chief Risk Officer divested 4,060 shares

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. MetLife Inc. shares valued at $274,456 were sold by Goulart Steven J on Aug 19. At $67.60 per share, Goulart Steven J sold 4,060 shares. The insider’s holdings dropped to 55,299 shares worth approximately $3.57 million following the completion of this transaction.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


Also, DEBEL MARLENE sold 4,060 shares, netting a total of over 274,456 in proceeds. Following the sale of shares at $67.60 each, the insider now holds 55,299 shares.

Before that, Goulart Steven J had sold 56,857 shares from its account. In a trade valued at $3,996,376, the EVP & Chief Investment Officer traded MetLife Inc. shares for $70.29 each. Upon closing the transaction, the insider’s holdings decreased to 56,857 shares, worth approximately $13.9 million.

As published in a research note from Wolfe Research on June 23, 2022, MetLife Inc. [MET] has been rated up from a Peer perform to an Outperform and the price target has been revised to $74 from $70. This represents a 12.81% premium over Wednesday’s closing price. Analysts at Citigroup started covering the stock with ‘”a Buy”‘ outlook in a report released in late May. As of January 26, 2022, Jefferies has initiated its “Buy” rating for MET. Earlier on January 21, 2022, Wolfe Research initiated its rating. Their recommendation was “a Peer perform” for MET stock.

Analyzing MET’s Price Performance

On Wednesday, MetLife Inc. [NYSE: MET] plunged -1.48% to $64.52. The stock’s lowest price that day was $64.50, but it reached a high of $66.22 in the same session. During the last five days, there has been a drop of approximately -2.85%. Over the course of the year, MetLife Inc. shares have jumped approximately 3.25%. Shares of the company reached a 52-week high of $73.18 on 04/21/22 and a 52-week low of $57.41 on 07/14/22. A 50-day SMA is recorded $64.41, while a 200-day SMA reached $65.57. Nevertheless, trading volume fell to 3.62 million shares from 4.22 million shares the previous day.

Support And Resistance Levels for MetLife Inc. (MET)

According to the 24-hour chart, there is a support level at 63.94, which, if violated, would cause prices to drop to 63.36. In the upper region, resistance lies at 65.66. The next price resistance is at 66.80. RSI (Relative Strength Index) is 44.50 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.57, which suggests the price will decrease in the coming days. Percent R is at 76.52%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.

Is MetLife Inc. subject to short interest?

Stocks of MetLife Inc. saw a sharp steep in short interest on Jul 14, 2022 dropping by -0.19 million shares to 11.27 million. Data from Yahoo Finance shows that the short interest on Jun 14, 2022 was 11.46 million shares. A decline of -1.69% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 2.43 of the overall float, the days-to-cover ratio (short ratio) decline to 2.43.

Which companies own the most shares of MetLife Inc. (MET)?

According to Dodge & Cox filings, the company currently owns 56,975,235 shares, which is about 7.14% of the total MET shares outstanding. The investor’s shares have plunged by -1,457,995 from its previous 13-F filing of 58433230.0 shares. With the completion of the sale transaction, The Vanguard Group, Inc.’s stake is now worth $3,484,652,850. Wellington Management Co. LLP reduced a -2.55% interest valued at $2.52 billion while BlackRock Fund Advisors sold a -911,334 stake. A total of -2,077,197 shares of MetLife Inc. were sold by SSgA Funds Management, Inc. during the quarter, and -2,761,492 were sold by T. Rowe Price Associates, Inc. In its current portfolio, Geode Capital Management LLC holds 12,071,893 shares valued at $776.58 million.

In terms of MetLife Inc. share price expectations, FactSet research, analysts set an average price target of $77.25 in the next 12 months, up nearly 17.58% from the previous closing price of $65.49. Analysts anticipate MetLife Inc. stock to reach $83.00 by 2022, with the lowest price target being $73.00. In spite of this, 18 analysts ranked MetLife Inc. stock as a Buy at the end of 2022. On January 12, 2022, UBS assigned a price target of “a Buy” to the stock and reiterated coverage with a $77.


Please enter your comment!
Please enter your name here